Ethinamate
Systematic (IUPAC) name | |
---|---|
(1-ethynylcyclohexyl)carbamate | |
Clinical data | |
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
Legal status |
|
Routes of administration | Oral |
Identifiers | |
CAS Number | 126-52-3 |
ATC code | None |
PubChem | CID 3284 |
IUPHAR/BPS | 7325 |
DrugBank | DB01031 |
ChemSpider | 3169 |
UNII | IAN371PP48 |
KEGG | D00703 |
ChEBI | CHEBI:4884 |
ChEMBL | CHEMBL1576 |
Chemical data | |
Formula | C9H13NO2 |
Molar mass | 167.205 g/mol |
| |
| |
(verify) |
Ethinamate (Valamin, Valmid) is a short-acting carbamate-derivative sedative-hypnotic medication used to treat insomnia. Regular use leads to drug tolerance, and it is usually not effective for more than 7 days. Prolonged use can lead to dependency.
Ethinamate has been replaced by other medicines (particularly benzodiazepines), and it is not available in the Netherlands, the United States or Canada.
Chemistry
Ethinamate (1-ethynylcyclohexanone carbamate) is synthesized by combining acetylene with cyclohexanone and then transforming the resulting carbinol into a carbamate by the subsequent reaction with phosgene, and later with ammonia. Some lithium metal or similar is used to make the acetylene react with the cyclohexanone in the first step.[1][2]
References
- ↑ H. Pfeiffer, K. Junkman, U.S. Patent 2,816,910 (1957)
- ↑ H. Emde, W. Grimme, DE 1021843 (1953)
|
This article is issued from Wikipedia - version of the Monday, October 12, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.